Firm launches study of mitral regurgitation device

01/16/2013 | MassDevice.com (Boston)

Phoenix Cardiac Devices has begun patient enrollment in a clinical study of its Bace system, which is used to treat mitral regurgitation without the need for open-heart procedures. The trial, which will involve 60 patients from Europe and India, will be used to help the company obtain CE mark approval for the device in Europe.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA